ArticlePDF Available

Abstract and Figures

Aims of this study: Centella asiatica has a reputation to restore decline cognitive function in traditional medicine and in animal model. However, little evidence regarding the efficacy of Centella asiatica from clinical trials is available. Therefore, the present study investigated the effect of Centella asiatica on cognitive function of healthy middle age volunteer. Materials and methods: Fourty one (22 females and 19 males) healthy middle age participants received the Centella asiatica capsules at various doses ranging 3 g to 4 g (according to body weight) once daily for 2 months. Cognitive performance was assessed using the Woodcock-Johnson Cognitive Abilities Test III (WJ CAT III) prior to the trial (baseline), 40 days, 60 days and 90 days (after treatment). Results: The results showed that the Centella asiatica enhanced many of the cognitive test measured at different time between males and females. Conclusion: Therefore, the present findings suggest the potential Centella asiatica to attenuate the age-related decline in cognitive function in healthy middle age and elderly adults. However, the precise mechanism(s) underlying theses effects still require further investigation.
Content may be subject to copyright.
European Journal of Scientific Research
ISSN 1450-216X Vol.31 No.4 (2009), pp.553-565
© EuroJournals Publishing, Inc. 2009
http://www.eurojournals.com/ejsr.htm
Comparison on Cognitive Effects of Centella Asiatica in Healthy
Middle Age Female and Male Volunteers
Roxana Dev Omar Dev
Department of Sports Studies, Faculty of Educational Studies
Universiti Putra Malaysia, Malaysia
Suhaila Mohamed
Department of Food Service and Management, Faculty of Food and Science Technology
Universiti Putra Malaysia, Malaysia
Zarida Hambali
Department of Pathology, Faculty of Medicine and Health Sciences
Universiti Putra Malaysia, Malaysia
Bahaman Abu Samah
Department of Professional Development and Continuing Education
Universiti Putra Malaysia, Malaysia
Abstract
Aims of this study: Centella asiatica has a reputation to restore decline cognitive function in
traditional medicine and in animal model. However, little evidence regarding the efficacy
of Centella asiatica from clinical trials is available. Therefore, the present study
investigated the effect of Centella asiatica on cognitive function of healthy middle age
volunteer.
Materials and methods: Fourty one (22 females and 19 males) healthy middle age
participants received the Centella asiatica capsules at various doses ranging 3 g to 4 g
(according to body weight) once daily for 2 months. Cognitive performance was assessed
using the Woodcock-Johnson Cognitive Abilities Test III (WJ CAT III) prior to the trial
(baseline), 40 days, 60 days and 90 days (after treatment).
Results: The results showed that the Centella asiatica enhanced many of the cognitive test
measured at different time between males and females.
Conclusion: Therefore, the present findings suggest the potential Centella asiatica to
attenuate the age-related decline in cognitive function in healthy middle age and elderly
adults. However, the precise mechanism(s) underlying theses effects still require further
investigation.
Keywords: Centella asiatica; Cognitive function; Middle age adults
1. Introduction
As we age a gradual deficit is present with regard to cognitive functions which normally does not
severely disturb the daily life activities related to the physical, mental, or social functioning in elderly
Comparison on Cognitive Effects of Centella Asiatica in Healthy Middle
Age Female and Male Volunteers 554
adults (Wattanathorn et al., 2008). The cognitive decline has been characterized as a diminution of
attentional processes, episodic and working memory, and processing and psychomotor speed
(Salthouse, 1994; Christensen, 2001). However, for extreme cases this condition can eventually
progress to clinically recognizable dementia (Chen et al., 2005; Amieva et al., 2005). Mild cognitive
impairment (MCI), a more recent introduced concept, is characterized by memory complaints in a non-
demented and otherwise healthy upper middle aged and older persons (Shah et al., 2000). MCI can
actually progresses to Alzheimer’s disease (AD) in 10-15% of individuals per annum compared with 1-
2 % in appropriate controls (Petersen et al., 1999).
Numerous studies suggested that the age-related cognitive decline can be prevented (Solfrizzi et
al., 1999). Therefore, a new approach aimed at controlling the decrease in cognitive function was
focused (Wattanathorn et al., 2008). Numerous previous studies had demonstrated that fruits,
vegetables and medicinal plants could prevent the occurrence of the neurochemical and behavioral
changes occurred in aging (Veerendra Kumar and Gupta, 2002).
Centella asiatica is a small perennial herbaceous plant, belonging to the Umbelliferae family.
Both the leaves and the entire plant can be used therapeutically. The active ingredients of Centella
asiatica are claimed to posess would healing properties (EMEA, 1998). Madecassic asid, asiaticoside
and asiatic acid act on fibroblast cells and equilibrate collagen fiber synthesis, whenever it is modified
(EMEA, 1998).
In ancient Ayurvedic medicine, C. asiatica is reputed to restore youth, memory and longevity
(Kapoor, 1990). Cognitive enhancing effects have been observed in rats following oral administration
of an aqueous extract of C. asiatica; this effect was associated with an antioxidant mechanism in the
CNS (Veerendra Kumar & Gupta, 2002). For example, an Ayurvedic formulation composed of four
herbs, including C. asiatica, is used to retard age and prevent dementia, and the herb combined with
milk is given to improve memory (Manyam, 1999). Whereas in Tradional Chinese Medicine (TCM),
C. asiatica has been used for combating physical and mental exhaustion (Brinkaus et al., 2000; Duke
& Ayensu, 1985).
Alterations in other neurotransmitter systems have been associated with Alzheimer’s Disease
(AD) pathology (Advokat & Pellergrin, 1992; Reinikainen et al., 1988; Seidl et al., 2001; Storga et al.,
1996). Some drugs that modulate neurotransmitter systems have shown some benefits in AD-related
symptoms (e.g., trazodone improved behavioral problems associated with AD) ( Lake and Grossberg,
1987; Lebert et al., 1994). An aqueous extract of C.asiatica leaf had shown a modulation on
dopamine, 5-hydroxytrptamine (5-HT) and noradrenalin systems in rat brain and improved learning
and memory processes in vivo (Nalini et al., 1992). Glutamate may induce neuronal degeneration by
over stimulation of N-methyl-D-aspartate (NMDA) receptors. Memantine, an NMDA receptor
antagonist, is licensed for the treatment of moderately severe to severe AD and it is therapeutically
effective (Winbald & Poritis, 1999; Reisberg et al., 2002). The triterpene asiatic acid (in C. asiatica)
and its derivatives have been shown to protect cortical neurons from glutamate-induced excitotoxicity
in vitro (Lee et al., 2000); thus, further research regarding the clinical potential of these compounds
may be warranted.
Eventhough, Centella asiatica products are widely available in market as cognitive booster,
however, supported document with valid biological data for humans are still limited. Hence, this work
attempts to compare the cognitive effects of Centella asiatica in healthy middle-age female and male
volunteers.
2. Materials and Methods
2.1. Subjects
Twenty two female and nineteen male healthy middle age volunteers (age range: 35–50 years; mean
age: 43.3 years and 44.2 years respectively) were recruited from the university, primarily via university
555 Roxana Dev Omar Dev, Suhaila Mohamed, Zarida Hambali and Bahaman Abu Samah
bulletin and posters. Before participating, volunteers signed a written consent form describing the
details of the study. In the consent form, subjects were informed that the purpose of the experiment
was to study the effects of herbal medications on cognitive functions in healthy middle age volunteers.
Volunteers initially participated in a structured telephone interview (acquiring data on age, sex,
medical condition, and self-reported alcohol, cigarette, caffeine and other supplements used).
Individuals meeting criteria (35–50 years old, fluent in English and Bahasa Malaysia, high school
diploma or equivalent, within 20% of ideal body weight, and no current medical problems) were
invited for a group briefing with the researcher.
At the briefing, subjects’ medical history were assessed and were given a thorough explanation
on details of the study. Subjects were told that they will be given one of two different types of
treatment/supplement. Baseline medical status which include the pre data intake on biomedical
parameters (glucose, total cholesterol, high density lipoprotein, and triglycerides) were assessed, to
determine if there were contraindications to their participating in the study (Derogatis, 1994).
Volunteers also completed the “Health Questionnaire,” a locally developed questionnaire, detailing
their medical history. Exclusion criteria included past or current medical conditions that would
contraindicate study participation; history of or current substance use disorder, current emotional or
psychiatric problems and pregnancy or intention to become pregnant. One male subject withdrew from
the study after completing one session for reasons unrelated to the study. Volunteers received token for
their participation in the research study.
2.2. Design
A clinical, placebo controlled, consisting of four trials was conducted. Subjects were tested at
baseline, after 40 days and 60 days of treatment/supplement, and after 30 days of washout period. A
random list of numbers was generated by computer. Subjects were randomly assigned to treatment or
placebo group. Placebo and Centella asiatica capsules had the same colour, texture and size.
A series of cognitive test and filling-in questionnaire were done. This procedure usually took
about 1 ½ hours. Subjects were not allowed to take any caffeine beverages or products and sweetened
(with glucose) beverage, at least an hour before the cognitive tests. Besides that, a three-day diet recall
was also taken.
Rigorous protocol was taken to maintain the quality of the study. Subjects were called every
week to remind on their herbal administration and also asked about adverse events. Subjects were
asked to call the researcher if they experienced any medical problems during the 90-day study period.
At the end of the study, they were also asked about adverse events.
2.3. Supplements
The supplements, herbal (Centella asiatica) or placebo (cornstarch) were given according to the
subjects’ body weight, 500 mg for each 10 kg of body weight. So, there were a range of 5 to 8
capsules taken daily per person. However, the intake is consistent for each individual for two months.
These capsules were prepared by herbal manufacturer, Tokotenaga Sdn. Bhd. (GMP), Sekudai, Johor.
2.4. Cognitive tests
Woodcock-Johnson III Cognitive Abilities Test (WJ III COG) was used in this study. The WJ III COG
contains 20 tests, each measuring different aspect of cognitive ability. The tests combine to form
clusters for interpretive purposes. Eight clusters were used for this study. Cluster interpretation
minimizes the danger of generalizing from the score for a single, narrow ability to a broad,
multifaceted ability. Cluster interpretation results in higher validity because usually more than one
component of a broad ability comprises the score that serves as the basis for interpretation. The entire
selection of tasks or clusters took approximately 1 hour.
Comparison on Cognitive Effects of Centella Asiatica in Healthy Middle
Age Female and Male Volunteers 556
The eight clusters of cognitive test were as follows; long-term retrieval (glr), visual-spatial
thinking (gv), speed processing (gs), short-term memory (gsm), working memory (gwm), broad
attention (gba), executive processes (gep), and delayed recall (gdr). However, for better understanding
in the selected tested clusters, the following descriptions of the WJ III COG Tests are given.
Visual-Auditory Learning: This thinking ability test requires the subject to learn, store, and
retrieve a series of visual-auditory associations. On this test of associative and meaningful memory,
the subject was asked to learn and recall rebuses (pictographic representations of words).
Spatial Relations: This visualization-of-spatial-relationships task requires the subject to
identify the two or three pieces that form a complete target shape. The difficulty increases as the
drawings of the pieces are flipped, rotated, and become more similar in appearance.
Concept Formation: This controlled-learning task involves categorical reasoning based on
principles of inductive logic. This test also measures an aspect of executive processing-flexibility in
thinking when required to shift one’s mental set frequently. The subject was presented with a complete
stimulus set from which to derive the rule for each item. This test does not include a memory
component.
Visual Matching: More specifically, it is a measure of perceptual speed. This task measures an
aspect of speed at which an individual can make visual symbol discriminations. The subject was asked
to locate and circle the two identical numbers in a row of six numbers. This task proceeds in difficulty
from single-digit numbers to triple-digit numbers and has a 3-minute time limit.
Numbers Reversed: Although this test primarily measures short-term memory span, it can also
be classified as a measure of working memory or attentional capacity. The test requires the individual
to hold span of numbers in immediate awareness (memory) while performing a mental operation on it
(reversing the sequence).
Auditory Working Memory: Besides measuring for short-term auditory memory span, it can
also be classified as a measure of working memory or divided attention. The subject was asked to
listen to a series that contains digits and words, such as “elephant, 1 shoe, 8, 2, apple.” The subject
then attempts to reorder the information, repeating first the objects in sequential order and then the
digits in sequential order. This task requires the ability to hold information in immediate awareness,
divide the information into two groups and shift attentional resources to the two new ordered
sequences.
Visual-Auditory Learning-Delayed: The subject was asked to relearn the associations presented
in a test occurred 30 minutes before. The ease of relearning a previously learned task provides an
index of retention over time.
Retrieval Fluency: This test measures fluency of retrieval from stored knowledge. The subject
was required to name as many examples as possible from given category within a 1-minute time
period. The task consists of three different categories: things to eat or drink, first names of people, and
animals.
Picture Recognition: The subject’s task is to recognize a subset of previously presented
pictures within a field of distracting pictures. To eliminate verbal mediation as a memory strategy,
varieties of the same type of object were used as the stimuli and distracters for each item (e.g., several
different flowers or several different hats). The difficulty of the items increases as the number of
pictures in the stimulus set increases.
Decision Speed: It requires the ability to make correct conceptual decisions quickly. It is a
test of cognitive efficiency that measures the speed of processing simple concepts. In each row, the
subject’s task was to locate quickly the two pictures that were most similar conceptually. This test has
a 1-minute time limit.
Memory for Words: In this test, the subject was asked to repeat lists of unrelated words in the
correct sequence.
Planning: This test measures the mental control process involved in determining, selecting,
and applying solutions to problems using forethought. The Planning test is a complex task that draws
557 Roxana Dev Omar Dev, Suhaila Mohamed, Zarida Hambali and Bahaman Abu Samah
upon fluid reasoning (gf ) and visual processing (gv) abilities (in particular, spatial scanning). In this
test, the subject was asked to trace a pattern without removing the pencil from the paper or retracing
any lines.
Pair Cancellation: Paired Cancellation provides information about executive processing,
attention/ concentration, and processing speed abilities. In a 1-minute time period, the ubject was
asked to locate and mark a repeated pattern as quickly as possible.
The following are the 8 cognitive clusters chosen for this study:
Long-term retrieval (glr): Long-term retrieval (Glr) in this study is the ability to store
information and fluently retrieve it later in the process of thinking. Many narrow abilities are included
in this broad category. For example, associative memory, ideational fluency, meaningful memory,
associative fluency, expressional fluency, naming facility, and word fluency are all examples of narrow
glr abilities. The long-term storage process begins through a process of transfer of information from
immediate awareness to the stores of declarative and procedural knowledge. The amount of time that
lapses between the initial task performance and recall of information related to that task is not critically
important in defining glr, as long as the information is not held in immediate awareness. Examples of
tests are: Visual-Auditory Learning and Retrieval Fluency.
Visual-spatial thinking (gv): Visual-spatial thinking (gv) in this study is the ability to perceive,
analyze, synthesize, and think with visual patterns, including the ability to store and recall visual
representations. This broad thinking ability includes a number of specific, narrow, visual or spatial
abilities, including the ability to manipulate objects or patterns mentally, the ability to identify visual
representations that appear in obscure or vague circumstances, and visual memory. Typical gv tasks
include recognizing rotations and reversal of figures, finding hidden figures, identifying incomplete or
distorted figures, and comprehending spatial configurations. Examples of tests are: Spatial Relations
and Picture Recognition.
Processing speed (gs): Speed processing (gs) in this study is the ability to perform automatic
cognitive tasks, particularly when measured under pressure to maintain focused attention. Speed
processing is an aspect of cognitive efficiency. Tasks that define gs typically are easy and most people
would get all items correct if the test were not highly speed. Examples of tests are: Visual Matching
and Decision Speed.
Short-term memory (gsm): Short-term memory (gsm) in this study is an aspect of cognitive
efficiency. Specifically, it is the ability to apprehend and hold information in immediate awareness
and then use it within a few seconds. Although it is possible that gsm may include other processes, it is
most closely identified with memory span. Gsm is a limited capacity system where information is
typically retained for only a few seconds before it is lost. Once an individual uses what is being
retained in immediate awareness to perform a new task, the information held is subsequently either
stored or lost. Examples of tests are: Numbers Reversed and Memory for Words.
Working memory (gwm): Working memory (gwm) in this study refers to the ability to hold
information in immediate awareness while performing a mental operation on the information.
Examples of tests are: Numbers Reversed and Auditory.
Delayed recall (gdr): The Delayed Recall cluster measures the ability to both recall and relearn
associations that were previously learned. The cluster consists of only one delayed recall test. The
single test is Visual-Auditory Learning-Delayed. It provides information about the ability to recall and
relearn associations that were learned anywhere from 30 minutes to 8 days earlier.
Executive Processes (gep): The Executive Processes (gep) cluster in this study includes three
aspects of executive functioning: strategic planning, proactive interference control, and the ability to
shift repeatedly one’s mental set. Examples of tests are: Concept Formation, Planning and Pair
Cancellation.
Broad Attention (gba): Attention is a complex and multifaceted construct by which an
individual focuses on certain stimuli for information processing. These facets include focused or
selective attention, vigilance or sustained attention, divided attention, and attentional capacity or
working memory. The Broad Attention includes three tests, each measuring a different aspect of
Comparison on Cognitive Effects of Centella Asiatica in Healthy Middle
Age Female and Male Volunteers 558
attention. Examples of tests are: Numbers Reversed (attentional capacity), Auditory Working Memory
(divided attention) and Pair Cancellation (sustain attention).
2.5. Data Analysis
All collected data were analyzed by using the SPSS 14.0.1. Exploratory Data Analysis (EDA) was
used to investigate the data normality and to identify/determine the correct statistical design
(parametric or non-parametric). A one-way ANOVA was used to analyzed the mean differences
between treated/supplemented and control while Repeated Measures Analysia of variance (ANOVA)
were used to compare mean differences between Centella asiatica and control in relation to time: 0, 40
days, 60 days and 90 days of the study. Bonferoni post hoc testing was done on both sets of
ANOVA’s, comparing treatment to placebo and each groups at each time point. All statistical tests
were done at 0.05 level of significance (p < 0.05).
3. Results
3.1. Characteristics of subjects
The baseline data about characteristics of subjects in all groups were shown in Table 3.1. No
significant difference of all parameters among various groups was observed.
Table 3.1: Characteristics of subjects
Baseline data Placebo (male) Placebo (female) Centella asiatcia
(male) Centella asiatica
(female) Significant p
Age 40.11±4.62 44.20±4.80 43.3±3.56 44.17±5.94 p = 0.23
Education year 14.4±3.77 17.2±3.23 14.33±4.62 15.6±5.42 p = 0.44
Brief Intelligence
Ability 38.53±5.21 40.62±3.11 38.32±5.70 39.55±6.70 p = 0.37
3.2. The effects of Centella asiatica (CA) on cognitive
Prior to the determination of Centella asiatica on cognitive function, baseline data and mean pre-dose
baseline scores for all four conditions (PLM= male placebo, PLF= female placebo, CAM= male
Centella asiatica and CAF= female Centella asiatica) for each cognitive test scores were subjected to a
one-way ANOVA. The ANOVA test revealed that there were significant differences in the mean test
score on long-term retrieval (glr), visual-spatial thinking (gv) and speed processing (gs), between the
four condition groups; F(3,37)=8.32, p=0.00, F(3,37)=9.39, p=0.00, and F(3,37)=4.22, p=0.01
respectively. Bonferoni Post Hoc multiple comparisons test show that there was a statistically
significant difference in the mean test score for the following pair: CAF dan PLF for glr, CAF and
PLF; CAM and PLM for gv and CAF and PLF for gs. Eventhough there were significant differences
seen on the above conditions during the pre-dose baseline score, none were seen for all placebo groups
across time.
A set of Repeated Measures Analysis of Variance (ANOVA) were performed to investigate
group differences in mean score of the cognitive tests across time while a One-Way ANOVA were
performed to compare group differences in mean score of the cognitive tests among groups (treated
subjects with Centella asiatica and placebo). The summarized table for mean scores obtained by four
groups are depicted in Table 3.2.
Not much significant differences were seen for most cognitive tests across time among the male
subjects. Male subjects who consumed Centella asiatica (CAM) only showed significant increase
(p<0.05) in scores across time for three out of the eight cognitive tests which were long-term retrieval
(glr), visual spatial thinking (gv) and speed processing (gs). Meanwhile, female subjects who
559 Roxana Dev Omar Dev, Suhaila Mohamed, Zarida Hambali and Bahaman Abu Samah
consumed Centella asiatica (CAF) showed significant increase (p<0.05) in scores across time for five
out of the eight cognitive tests. The tests are: long-term retrieval (glr), short-term memory (gsm),
working memory (gwm), executive process (gep), and delayed recall (gdr). No significant differences
were seen on placebo subjects across time. For detailed findings, data obtained will be dealt
individually by each clusters of cognitive test performance.
Table 3.2: Mean pre-dose baseline raw scores and change from baseline scores for each condition at given
post-dose time point on selected cognitive performance
Post-dose Wash-out
Measure Pre-dose baseline score 40 days 60 days 90th day
Long term PLM 81.83 ± 9.74 88.22 ± 8.26 90.33 ± 9.3 91.56 ± 9.78 F(3,32) = 1.40, p = 0.26
retrieval PLF 89.00 ± 14.56 91.15 ± 6.83 94 ± 12.6 98.60 ± 7.39 F(3,36) = 2.06, p = 0.13
(glr) CAM 72.60 ± 12.81 78.45 ± 15.32 85.6 ± 15.7** 86.70 ± 15.13** F(3,36) = 3.98, p = 0.02
CAF 75.71 ± 13.50* 83.92 ± 13.52* 88.88 ± 12.57*/** 92.17 ± 13.4*/** F(3,44) = 3.49, p= 0.02
F(3,37) = 8.32, F(3,37) = 7.33, F(3,37) = 5.99, F(3,37) = 3.21,
p = 0.00 p = 0.00 p = 0.00 p = 0.03
visual PLM 56.50 ± 4.14 60.60 ± 2.14 59.90 ± 3.93 60.60 ± 2.63 F(3,32) = 2.27, p = 0.08
spatial PLF 59.80 ± 2.61 60.80 ± 1.61 62.05 ± 2.85 59.50 ± 3.5 F(3,36) = 1.38, p = 0.23
thinking CAM 50.33 ± 5.61 58.67 ± 3.43 60.33 ± 3.85 62.23 ± 3.35** F(3,36) = 4.99, p = 0.01
(gv) CAF 50.80 ± 5.89* 52.67 ± 5.49 53.33 ± 3.93 52.06 ± 4.15 F(3,44) = 0.26, p = 0.85
F(3,37) = 9.39, F(3,37) = 1.49, F(3,37) = 0.35, F(3,36) = 0.52,
p = 0.00 p = 0.23 p = 0.79 p = 0.67
Speed PLM 36.1 ± 4.77 36.70 ± 4.96 39.00 ± 3.07 39.75 ± 4.46 F(3,32) = 1.22, p = 0.33
processing PLF 42.9 ± 4.03 43.6 ± 3.80 44.45 ± 1.40 44.60 ± 4.18 F(3,36) = 1.49, p = 0.17
(gs) CAM 37.94 ± 3.67 39.17±3.42 40.61 ± 3.53 43.61 ± 4.7** F(3,36) = 4.86, p = 0.01
CAF 39.63 ± 4.95 42.00 ± 5.07* 42.59 ± 5.35 43.13 ± 4.36 F(3,44) = 4.72, p= 0.06
F(3,37) = 4.22, F(3,36) = 4.81, F(3,36) = 1.12, F(3,37) = 2.32,
p = 0.01 p = 0.01 p = 0.35 p = 0.09
Table 3.2: (continued)
Post-dose Wash-out
Measure Pre-dose baseline score 40 days 60 days 90th day
short-term PLM 17.67 ± 2.96 18.61 ± 4.0 18.78 ± 2.9 20.00 ± 2.96 F(3,32) = 0.82, p = 0.49
memory PLF 16.70 ± 4.41 18.65 ± 3.13 18.9 ± 3.04 20.10 ± 2.77 F(3,36) = 1.72, p = 0.18
(gsm) CAM 15.25 ± 2.32 16.8 ± 2.6 17.20 ± 2.36 18.20 ± 3.65 F(3,36) = 1.63, p = 0.19
CAF 15.64 ± 2.29 16.83 ± 2.14 19.67 ± 3.11** 19.79 ± 3.48** F(3,44) = 3.34, p = 0.02
F(3,37) = 1.18, F(3,37) = 0.94, F(3,37) = 1.16, F(3,37) = 0.83,
p = 0.33 p = 0.43 p = 0.34 p = 0.48
working PLM 18.3 ± 5.23 20.4 ± 5.66 20.20 ± 4.23 21.80 ± 6.5 F(3,32) = 1.95, p = 0.41
memory PLF 19.75 ± 6.37 22.50 ± 4.18 22.60 ± 5.31 22.75 ± 5.62 F(3,36) = 0.70, p = 0.56
(gwm) CAM 19.17 ± 3.04 21.56 ± 3.26 23.06 ± 3.76 22.28 ± 4.24 F(3,36) = 1.96, p = 0.33
CAF 18.59 ± 3.37 22.00 ± 2.86** 23.92 ± 4.2** 22.79 ± 5.13** F(3,44) = 3.17, p = 0.03
F(3,36) = 0.49, F(3,36) = 0.48, F(3,37) = 0.93, F(3,37) = 0.08,
p = 0.69 p = 0.70 p = 0.44 p = 0.97
executive PLM 61.53 ± 12.21 66.92 ± 5.84 67.48 ± 12.67 69.63 ± 6.07 F(3,32) = 2.38, p = 0.08
process PLF 56.88 ± 11.01 58.64 ± 6.72 59.58 ± 10.86 70.11 ± 7.34 F(3,36) = 2.94, p = 0.07
(gep) CAM 65.53 ± 13.77 71.71 ± 11.04 71.93 ± 15.44 77.95 ± 17.63 F(3,36) = 3.12, p = 0.06
CAF 54.97 ± 10.60 68.25 ± 13.52* 80.46 ± 9.43** 70.60 ± 18.72 F(3,44) =5.23, p = 0.01
F(3,37) = 1.44, F(3,36) = 3.77, F(3,37) = 1.89, F(3,37 ) =
2.42,
p = 0.25 p = 0.02 p = 0.15 p = 0.08
Comparison on Cognitive Effects of Centella Asiatica in Healthy Middle
Age Female and Male Volunteers 560
Table 3.2: (continued)
Post-dose Wash-out
Measure Pre-dose baseline score 40 days 60 days 90th day
delayed PLM 90.78 ± 27.81 96.67 ± 10.28 95.56 ± 10.51 95.11 ± 13.71 F(3,32) = 1.73, p = 0.18
recall PLF 94.7 ± 30.43 96.60 ± 16.30 97.50 ± 9.48 97.78 ± 9.39 F(3,35) = 1.37, p = 0.28
(gdr) CAM 82.80 ± 20.99 85.70 ± 26.92* 91.50 ± 24.72 95.70 ± 19.19 F(3,36) = 1.85, p = 0.15
CAF 87.73 ± 20.76 96.45 ± 21.05 103.42 ± 15.77*/** 109.45 ± 17.13*/** F(3,44) = 4.79, p = 0.01
F(3,36) = 2.68, F(3,36) = 5.19, F(3,37) = 4.38, F(3,37) = 3.32,
p = 0.06 p = 0.00 p = 0.01 p = 0.03
broad PLM 32.2 ± 5.92 35.10 ± 4.75 35.60 ± 4.03 36.70 ± 4.74 F(3,32) = 1.65, p = 0.14
attention PLF 35.75 ± 8.16 38.67 ± 9.08 37.00 ± 3.33 35.83 ± 7.20 F(3,36) = 0.47, p = 0.71
(gba) CAM 34.00 ± 1.73 36.22 ± 2.49 38.22 ± 9.32 36.78 ± 2.86 F(3,36) = 1.53, p = 0.22
CAF 34.50 ± 4.63 36.60 ±3.34 39.20 ± 6.27 37.40 ± 3.44 F(3,44) = 0.43, p = 0.74
F(3,37) = 0.68, F(3,37) = 0.73, F(3,37) = 1.68, F(3,37) = 0.18,
p = 0.57 p = 0.54 p = 0.09 p = 0.91
Shown are mean scores and S.E.M of cognitive test performance for each of the four conditions ((PLM = male placebo;
PLF = female placebo; CAM = male Centella asiatica, CAF = female Centella asiatica.
* p-value <0.05 when compared with placebo group (analysis between treatment), ** p-value<0.05 when compared with
baseline pre-dose score (analysis between trials).
4. Discussion
The present study investigated the effect of Centella asiatica on the cognitive performance in the
middle-age adults. The results indicate that the subjects who took Centella asiatica performed
significantly better in selected cognitive tests. This finding adds to the earlier findings that Centella
asiatica could have beneficial effects on the cognitive functions of subjects. Interestingly, females
showed more positive response to the ingestion of Centella asiatica as compared to male counterparts.
The results from this study also suggest that the ingestion of Centella asiatica can modulate differently
at different time period in males and females on cognitive test in the healthy middle-age adults.
Moreover, from this study ingestion of Centella asiatica can modulate differently on different
cognitive clusters in males and females.
There were three cognitive tests (that had significant differences across time) seen to increase
significantly for males who ingested Centella asiatica. Long term retrieval (glr) were seen
significantly different between trial period which began to modulate at 60th day of the trials and lasted
till the 90th day of the trial period. The other two which were speed processing (gs) and visual spatial
thinking (gv) were significantly different across time at the 90th day of the trial.
Earlier modulation was observed from female subjects who were supplemented with Centella
asiatica. Working memory (gwm) significantly increased at the 40th day of the trial. The other
cognitive tests such as long-term retrieval (glr), short-term memory (gsm), delayed recall (gdr) and
executive processes (gep) significantly increased at the 60th day of trial. Increment on glr, gsm and
gdr lasted till the 90th day of trial period, while mean scores for gwm and gep decrease at the 90th day
period. This marks the uniqueness of observation for female subjects.
Recently, it was found that the long-term memory retrieval process involved the function of
right prefrontal cortex (PFC) (Bukner and Petersen, 1996) whereas the visual-spatial thinking was
reported to involve the hippocampus (Moser and Moser, 1998). Previous studies demonstrated that the
speed processing involved the function of dorsal and ventral pre-frontal cortex (Rypma & D’Esposito,
1999; Crespo-Facorro et al., 1999). The flexible capacity to store and manipulate information, termed
short-term memory is extremely important to our effective cognitive functioning (Gathercole, 1999).
The regions that are involved are more complex than most cognitive abilities. Short-term memory are
mostly activated at the left prefrontal region, right frontal areas, biparietal areas and surprisingly the
left cerebellum (Andreasen et al., 1995).
The last two decades have witnessed a dramatic increase in research on working memory.
Performance of a new working memory task, one that has not previously been used in functional
561 Roxana Dev Omar Dev, Suhaila Mohamed, Zarida Hambali and Bahaman Abu Samah
neuroimaging study, produced a distributed network of cerebral activation (Garavan et al., 2000).
Regional activation was largely consistent with the circuitry thought to underlie the function of
working memory, incorporating dorsolateral prefrontal, premotor and parietal areas (Rypma &
D’Esposito, 1999; D’Esposito et al., 1998; Jonides et al., 1993).
The role of executive functioning/processes and working memory constructs in clinical and
individual differences research may, in part, have prompted interest in identifying the neuroanatomical
locations and mechanisms that subserve both (Garavan, 2000). A consensus implicating dorsolateral
prefrontal cortex as critical for executive functioning has emerged as this region has been observed in a
number of studies using a number of different tasks (D’Esposito et al., 1995; Owen et al., 1996;
Salmon et al., 1996; Collette et al., 1999). However, it would be a mistake to presume that executive
processes are located solely in prefrontal regions (Garavan et al., 2000). Those studies that have
localized executive functions to the dorsolateral prefrontal cortex have also observed extensive parietal,
premotor, cingulated, occipital and cerebellar activation (Garavan et al., 2000). Consistent with these
findings, recent functional imaging studies of ‘classic’ executive tasks such as the Tower of London
and Raven’s Progressive Matrices test reveal extensive activation in frontal, as well as temporal,
parietal and occipital lobes and in the cerebellum (Berman et al., 1995; Baker at al., 1996; Nagahama et
al., 1996; Prabhakaran et al., 1997).
It is known that the anterior angulate cortex, on the medial surface of the frontal lobes of the
brain is widely believed to be involved in the regulation of attention (D’Esposito et al., 1995). Beyond
this however, its specific contribution to cognition remains disputed by many studies. Selective visual
attention involves dynamic interplay between attentional control systems and sensory brain structures
(Hopfinger et al., 2000). Superior frontal, inferior parietal and superior temporal cortex were
selectively activated by cues, indicating that theses structures are part of a network for attentional
control (Hopfinger et al., 2000). In a study by Kastner & Ungerheinder (2000) visual attention
involves in the area of frontal and parietal cortex. While, Corbetta & Shulman (2002) reviewed
evidence for partially segregated networks of brain areas that carry out different attentional functions.
One system (top-down), which includes parts of the intraparietal cortex and superior frontal cortex, is
involved in preparing and applying goal-directed selection for stimuli and responses. The other
system, which includes the temporoparietal cortex and inferior frontal cortex, and is largely lateralized
to the right hemisphere, is not involved in top-down selection (Corbetta & Shulman, 2002).
In summary, the prefrontal cortex has been the focus of considerable scientific investigation in
recent years, owing in part to the growing recognition that dysfunction of this region and associated
circuitry probably underlies many of the cognitive and behavioral disturbances associated with major
neuropsychiatric disorders such as attention-deficit hyperactive disorder (ADHD) and schizophrenia
(Dalley et al., 2004). Recent findings in rodents and non-human primates suggest that divergent
cognitive processes may be carried out by anatomically distinct sub-regions of prefrontal cortex
(Aggleton et al., 1995; Walton et al., 2003), although the extent to which these processes can be
considered functionally 100% homologous in human remains controversial (Brown, 2003). The
prefrontal cortex also targets, in a reciprocal and topographical manner, the main nuclei of origin of the
major forebrain cholinergic and monoaminergic neutotransmitter systems, including noradrenaline
(NA), dopamine (DA), serotonin (5-HT) and acetylcholine (AcH) (Birrell & Brown, 2000). These
systems act in turn to neuro-modulate cortical networks by influencing inhibitory and excitatory
synaptic transmission as well as the other cortical processes (Arnsten, 1997).
Alterations in neurotransmitter systems have been associated with Alzheimer’s Disease (AD)
pathology. (Advokat & Pellegrin, 1992; Fowler et al., 1992; Reinikainen et al., 1988). Some drugs
that modulate neurotransmitter systems have shown some benefits in AD-related systems (Lebert at al.,
1994). A distinct role for norepinephrine was seen for long-term retrieval, when a study on rats
showed that role of norepinephrine (adrenergic signaling in the hippocampus) was critical in retrieval
(Murchinson et al., 2004). For visual-spatial task, both acetylcholine and serotonin in hippocampus
were simultaneously activated (Stancampiano et al., 1999). Previous studies demonstrated that
working memory could be modulated by dopamine, norepinephrine and other main neurotransmitters
Comparison on Cognitive Effects of Centella Asiatica in Healthy Middle
Age Female and Male Volunteers 562
(Goldman-Rakic et al., 2000; Arnsten & Robbins, 2002). Meanwhile, dopamine has been prominently
studied as a crucial neurotransmitter for tuning neuronal and circuit responses during executive
processes (Goldberg & Weinberger, 2004). Study by Robbins (1997) showed that acetylcholine has
important roles in attentional function, compared to dopamine and norepinephrine.
Further studies have showed the extract of C. asiatica leaf to be sedative, antidepressant and
potentially cholinomimetic in vivo (Sakina, & Dandiya, 1990). These findings suggest that C. asiatica
may be appropriate to treat symptoms of depression and anxiety in AD, and that it may also influence
cholinergic activity, and thus cognitive function. An aqueous extract of C.asiatica leaf modulated
dopamine, 5-HT and noradrenaline systems in rat brain and improved learning, short-term and working
memory in vivo (Nalini et al., 1992). Cognitive-enhancing effects have also been observed in rats
following oral administration of an aqueous extract of C. asiatica; which was associated with an
antioxidant mechanism in the central nervous system (Kumar and Gupta, 2002b). Most recent study
by Wattanathorn et al., 2008, showed that high dose of C. asiatica extract enhanced working memory,
increased mood and alertness in healthy elderly volunteers.
Therefore, the effects of Centella asiatica on working memory (gwm), short-term memory
(gsm) and executive processes (gep) might partly occur via the modulation of dopamine in prefrontal
cortex. Meanwhile, long-term retrieval (glr), and visual spatial thinking (gv) might partly occur via
the modulation of norepinephrine, serotonin and acetylcholine respectively in various parts of the
frontal cortex and hippocampus.
In conclusion, this study is the first study to demonstrate significant differences effects of
Centella asiatica on cognitive performances when gender is compared. Males seemed to respond more
to glr, gv and speed processing (gs) after consuming Centella asiatica, while females increased better
in their glr, gsm, gwm, gep and delayed recall (gdr). Another interesting finding was no significant
differences were seen on broad attention on both gender. However, precise mechanism underlying
these effects still require further investigation.
Acknowledgement
This study was supported by Faculty of Educational Studies and Research Management Center,
Universiti Putra Malaysia, Malaysia.
References
[1] Advokat C., Pellegrin A. I., 1992. Excitatory amino acids and memory: evidence from research
on Alzheimer's disease and behavioral pharmacology. Neuroscience and Biobehavioral
Reviews 16(1), 13-24.
[2] Aggleton, J. P., Neave, N., Nagle, S., Hunt, P. R., 1995. A comparison of the effects of
anterior thalamic, mamillary body and fornix lesions on reinforced spatial alternation.
Behavioural Brain Research 68(1), 91-101.
[3] Amieva, H., Jacmin-Gadda, H., Orgogozo, J.M., Le Carret, N., Helmer, C., Letenneur, L.,
Barberger-Gateau, P., Fabrigoule, C., Dartigues, J.F., 2005. The 9-year cognitive decline
before dementia of the Alzheimer type: a prospective population-based study. Brain 128, 1093-
1101.
[4] Andreasen, N.C., O'Leary, D.S., Cizadlo, T., Arndt, S., Rezai, K., Watkins, G.L., Ponto, L.L.,
Hichwa, R.D, 1995. Remembering the past: two facets of episodic memory explored with
positron emission tomography. American Journal of Psychiatry 152, 1576-1585.
[5] Andreasen, N. C., O'Leary, D. S., Arndt, S., Cizadlo, T., Hurtig, R., Rezai, K., Watkins, G.
L., Ponto, L. L., Hichwa, R.D., 1995. Short-term and long-term verbal memory: a positron
emission tomography study. Proceedings of the National Academy of Sciences of United States
of America 92(11), 5111-5115.
563 Roxana Dev Omar Dev, Suhaila Mohamed, Zarida Hambali and Bahaman Abu Samah
[6] Andreasen, N. C., O'Leary, D. S., Cizadlo, T., Arndt, S., Rezai, K., Watkins, G.L., Ponto, L.
L., Hichwa, R.D., 1995. PET Studies of Memory: Novel versus Practiced Free Recall of Word
Lists. NeuroImage 2(4), 296-305.
[7] Arnsten, A. F. T., 1997. Catecholamine regulation of the prefrontal cortex. Journal of
Psychopharmacology 11(2), 151-162.
[8] Arnsten, A.F.T., Robbins, T.W., 2002. Neurochemical modulation of prefrontal cortical
function in humans and animals. in The Frontal Lobes. D. Stuss and R. Knight, Eds., Oxford
University Press, New York, NY, pp 51-84.
[9] Brinkhaus, B., Lindner, M., Schuppan, D., Hahn, E. G., 2000. Chemical, pharmacological and
clinical profile of the East Asian medical plant Centella asiatica. Phytomedicine 7(5), 427-48.
[10] Buckner, R.L., Petersen, S.E., 1996. What has neuroimaging told us about prefrontal cortex
involvement in long-term memory retrieval? Seminars in the Neurosciences 8, 47-55.
[11] Berman, K.F., Ostrem, J.L., Randolph, C., Gold, J., Goldberg, T.E., Coppola, R., Carson, R.E.,
Herscovitch, P., Weinberger, D.R., 1995. Physiological activation of a cortical network during
performance of the Wisconsin Card Sorting Test: A positron emission tomography study.
Neuropsychologia 33(8), 1027-1046.
[12] Baker, S.C., Rogers, R.D., Owen, A.M., Frith, C.D., Dolan, R.J., Frawckowiak, R.S.J.,
Robbins, T.W., 1996. Neural systems engaged by planning: a PET study of the Tower of
London task. Neuropsychologia 34, 515–526.
[13] Brown, L., 2003. Test of nonverbal intelligence: a language-tree measure of cognitive ability.
In Handbook of nonverbal assessment. M.R. Steve, Ed., Kluwer Academic Publishers, New
York, pp 191-221.
[14] Birrell, J.M., Brown V.J., 2000. Medial Frontal Cortex Mediates Perceptual Attentional Set
Shifting in the Rat. The Journal of Neuroscience 20(11), 4320-4324.
[15] Christensen, H., 2001. What cognitive changes can be expected with normal ageing? The
Australia and New Zealand Journal of Psychiatry 35, 768-775.
[16] Crespo-Facorro, B., Paradiso, S. Andreasen, N.C., O'Leary, D.S., Watkins, G.L., Ponto, L.L.B.,
Hichwa, R.D., 1999. Recalling wod lists reveals "cognitive dysmetria" in schizophrenia: A
positron emission tomography study. American Journal of Psychiatry 156, 386-392.
[17] Crespo-Facorro, B., Kim, J., Andreasen, N.C., O'Leary, D.S., Wiser, A.K., Bailey, J.M., Harris,
G., Magnotta, V.A., 1999. Human frontal cortex: An MRI-based parcellation method.
NeuroImage 10(5), 500-519.
[18] Corbetta, M., Shulman, G. L., 2002. Control of goal-directed and stimulus-driven attention in
the brain. Neuroscience 3, 201.
[19] Chen, Y., Han, T., Rui, Y., Yin, M., Qin, L., Zheng, H., 2005. Effects of total triterpenes of
Centella asiatica on the corticosterone levels in serum and contents of monoamine in
depression rat brain. Journal of Chinese Medicinal 28, 492-496.
[20] Collette, F., Salmon, E., Van der Linden, M., Chicherio, C., Belleville, S., Degueldre, C., 1999.
Regional brain activity during tasks devoted to the central executive of working memory.
Cognitive Brain Research 7, 411–417.
[21] D'Esposito, M., Detre, J.A., Alsop, D.C., Shin, R.K., Atlas, S., Grossman, M., 1995. The neural
basis of the central executive system of working memory. Nature 378,279–281.
[22] D'Esposito, M., Aguirre, G.K., Zarahn, E., Ballard, D., Shin, R.K., Lease, J., 1998. Functional
MRI studies of spatial and nonspatial working memory. Cognitive Brain Research 7, 1–13.
[23] Duke, J. A., Ayensu, E.A., 1985. Medicinal plants of China. Reference Publications, Algonac,
Michigan, 2 vols, 705 pp.
[24] Derogatis, L.R., 1994. Symptom Checklist-90-R: Administration, Scoring, and Procedures
Manual. 3rd ed. Minneapolis, MN: National Computer Systems.
[25] Dalley, J.W., Cardinal, R.N., Robbins, T. W., 2004. Prefrontal executive and cognitive
functions in rodents: neural and neurochemical substrates. Neuroscience & Biobehavioral
Reviews 28(7), 771-784.
Comparison on Cognitive Effects of Centella Asiatica in Healthy Middle
Age Female and Male Volunteers 564
[26] EMEA (The European Agency for the Evaluation of Medicinal Products), 1998. Centella
asiatica extractum - summary report.
[27] Gathercole S.E., 1999. Cognitive approaches to the development of short-term memory.
Trends in Cognitive Sciences 3(11), 410-419.
[28] Garavan, H., Ross, T.J., Li, S.-J., Stein, E.A., 2000. A Parametric Manipulation of Central
Executive Functioning. Cerebral Cortex 10(6), 585-592.
[29] Goldman-Rakic, P. S., Muly, E. C., Williams, G. V., 2000. D1 receptors in prefrontal cells and
circuits. Brain Research Reviews 31(2-3), 295-301.
[30] Goldberg, T.E., Weinberger, D.R., 2004. Genes and the parsing of cognitive processes. Trends
in Cognitive Sciences 8(7), 325-335.
[31] Hopfinger, J. B., Buonocore, M.H., Mangun, G.R., 2000.The neural mechanisms of top-down
attentional control. Nature Neuroscience 3, 284 – 291.
[32] Jonides, J., Smith, E.E., Koeppe, R.A., Awh, E., Minoshima, S., Mintun, M., 1993. Spatial
working memory as revealed by PET. Nature 363, 623–625.
[33] Kapoor, L.D., 1990. Handbook of Ayurvedic medicinal plants. CRC Press Inc., Boca Raton,
U.S.A. Blackwell Series Ltd., 473-475.
[34] Kastner, S., Ungerleider, L.G., 2000. Mechanisms of Visual Attention in the Human
Cortex.Annual Review of Neuroscience 23, 315-341.
[35] Kumar, M.H.V., Gupta Y.K., 2002. Effect of different extracts of Centella asiatica on
cognition and markers of oxidative stress in rats. Journal of Ethnopharmacology 79, 253-260.
[36] Lebert, F., Pasquier, F., Petit, H., 1994. Behavioral effects of trazodone in Alzheimer's disease.
The Journal of Clinical Psychiatry 55(12), 536-538.
[37] Lee, M.K., Kim, S.R., Sung, S.H., Lim, D., Kim, H., Choi, H., Park, H.K., Je, S., Ki, Y.C.,
2000. Asiatic acid derivatives protect cultured cortical neurons from glutamate-induced
excitotoxicity. Research Communications in Molecular Pathology & Pharmacology 108(1-2),
75-86.
[38] Manyam, B.V., 1999. Dementia in Ayurveda. The Journal of Alternative and Complementary
Medicine, 5(1), 81-88.
[39] Moser, M.B., Moser, E.I., 1998. Functional differentiation in the hippocampus. Hippocampus
8(6), 608-19.
[40] Murchinson, C.F., Zhang, X.Y., Zhang, W.P., Ouyang, M., Lee, A., Thomas, S.A., 2004. A
distinct role for norepinephrine in memory retrieval. Cell 117, 131–143.
[41] Nagahama, Y., Fukuyama, H., Yamauchi, H., Matsuzaki, S., Konishi, J., Shibasaki, H.,
Kimura, J., 1996. Cerebral activation during performance of a card sorting test. Brain 119,
1667–1675.
[42] Nalini, K., Arroor, A.R., Karanth, K.S., Roa, A., 1992. Effact of Centella asiatica fresh leaf
aqueous extract on learning and memory and biogenic amine turnover in albino rats. Fitoterapia
XIII (3), 232-237.
[43] Owen, A.M., Evans, A.C., Petrides, M.,1996. Evidence for a two-stage model of spatial
working memory processing within the lateral frontal cortex: a positron emission tomography
study. Cerebral Cortex 6, 31–38.
[44] Prabhakaran, V., Smith, J.A.L., Desmond, J.E., Glover, G.H., Gabrieli, J.D.E., 1997. Neural
substrates of fluid reasoning: an fMRI study of neocortical activation during performance of the
Raven's Progressive Matrices Test. Cognitive Psychology 33, 43–63.
[45] Petersen, R.C., Smith, G. E., Waring, S.C., Ivnik, R. J., Tangalos, E.G., Kokmen, E., 1999.
Mild Cognitive Impairment-Clinical Characterization and Outcome. Archives of Neurology 56,
303-308.
[46] Reinikainen, K. J., Paljarvi, L., Huuskonen, M., Soininen, H., Laakso, M., Riekkinen, P.J.,
1988. A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in
Alzheimer's disease. Journal of the Neurological Sciences 84(1), 101-116.
565 Roxana Dev Omar Dev, Suhaila Mohamed, Zarida Hambali and Bahaman Abu Samah
[47] Reinikainen, K., Paljarvi, L., Halonen, T., Malminen, O., Kosma, V., Laakso, M.,Riekkinen,
P.,1988. Dopaminergic system and monoamine oxidase-B Activity in Alzheimer's disease.
Neurobiology of Aging 9, 245 – 252.
[48] Reisberg, B., Franssen, E. H., Souren, L.E.M., Auer, S.R., Akram, I., Kenowsky, S., 2002.
Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias: Management
and treatment import. American Journal of Alzheimer's Disease and Other Dementias 17(4),
202-212.
[49] Rypma, B., D’Esposito, M., 1999. The roles of prefrontal brain regions in components of
working memory: Effects of memory load and individual differences. Proceedings of the
National Academy of Science of the USA 96, 6558–6563.
[50] Robbins, T.W., 1997. Arousal system and attentional processes. Biological Psychology 45,
57-71.
[51] Salmon, E., Van der Linden, M., Collette, F., Delfiore, G., Maquet, P., Degueldre, C., Luxen,
A., Franck, G., 1996. Regional brain activity during working memory tasks. Brain 119, 1617–
1625.
[52] Solfrizzi, V., Panza, F., Torres, F., Mastroianni, F., Del Parigi, A., Venezia, A., Capurso, A.,
1999. High monounsaturated fatty acids intake protects against age-related cognitive decline.
Neurology 52, 1563.
[53] Storga, D., Vrecko, K., Birkmayer, J. G. D., Reibnegger G., 1996. Monoaminergic
neurotransmitters, their precursors and metabolites in brains of Alzheimer patients.
Neuroscience Letters 203(1), 29-32.
[54] Stancampiano, R., Cocco, S., Cugusi, C., Sarais, L., Fadda F., 1999. Serotonin and
acetylcholine release response in the rat hippocampus during a spatial memory task.
Neuroscience 89(4), 1135-1143.
[55] Sakina, M.R., Dandiya, P.C., 1990. A psycho-neuropharmacological profile of Centella
asiatica extract. Fitoterapia 61, 291-296.
[56] Salthouse, T.A., 1994. Aging associations: influence of speed on adult age differences in
associative learning. Journal of Experimental Psychology, Learning, Memory and Cognition
20, 1486-1503.
[57] Shah, Y., Tangalos, E., Petersen, R., 2000. Mild cognitive impairment: when is it precursor to
Alzheimer’s disease? Geriatrics 55, 62-68.
[58] Veerendra Kumar, M. H., Gupta, Y.K., 2002. Effect of different extracts of Centella asiatica
on cognition and markers of oxidative stress in rats. Journal of Ethnopharmacology 79(2), 253-
260.
[59] Winblad, B., Poritis, N., 1999. Memantine in severe dementia: results of the 9M-best study
(benefit and efficacy in severly demented patients during treatment with memantine).
International Journal of Geriatric Psychiatry 14(2), 135 –146.
[60] Walton, M.E., Bannerman, D.M., Alterescu, K., Rushworth, M.F.S., 2003. Functional
Specialization within Medial Frontal Cortex of the Anterior Cingulate for Evaluating Effort-
Related Decisions. The Journal of Neuroscience 23(16), 6475-6479.
[61] Wattanathorn, J., Mator, L., Muchimapura, S., Tongu, T., Pasuriwong, O., Piyawatkul, N.,
Yimtae, K., Sripanidkuchai, B., Singkhoraard, J., 2008. Positive modulation of cognition and
mood in healthy elderly volunteer following the administration of Centella asiatica. Journal of
Ethnopharmacology 116, 325-332
... A doubleblind trial developed more than four decades ago [124] showed significant increases in the general mental ability, attention and concentration of mentally retarded children treated with Centella asiatica (0.5 g/day during 6 months). Studies also reported improvements in cognitive function after Centella asiatica treatment in adult humans after stroke [125], as well as in healthy middle aged [126] and elderly individuals [127][128][129]. ...
... Increase in the general mental ability, attention and concentration of mentally retarded children. Improvement in adult humans after stroke, in healthy middle age and elderly individuals [124][125][126][127][128][129]. ClinicalTrials.gov, ...
... In this context, it is important to note the clear distinction between cognitive enhancers and disease modifying strategies [155]. Particularly in the clinical studies involving patients (MS, mental retardation, Down's syndrome) [124,141,144] or elderly subjects [116,119,122,[126][127][128][129]131,132,138], it is likely that, due to the antioxidant and antiinflammatory effects resulting from NRF2-related downstream proteins, the upregulation of this pathway prevented cognitive decline directly by preventing neurodegeneration, thus displaying an indirect effect in promoting cognition. ...
Article
Full-text available
Nuclear factor (erythroid-derived 2)-like 2 (NRF2) is a redox-sensitive transcription factor that binds to the antioxidant response element consensus sequence, decreasing reactive oxygen species and regulating the transcription of a wide array of genes, including antioxidant and detoxifying enzymes, regulating genes involved in mitochondrial function and biogenesis. Moreover, NRF2 has been shown to directly regulate the expression of anti-inflammatory mediators reducing the expression of pro-inflammatory cytokines. In recent years, attention has turned to the role NRF2 plays in the brain in different diseases such Alzheimer's disease, Parkinson’s disease, Huntington’s disease and others. This review focused on the evidence, derived in vitro, in vivo and from clinical trials, supporting a role for NRF2 activation in maintaining and improving cognitive function and how its activation can be used to elicit neuroprotection and lead to cognitive enhancement. The review also brings a critical discussion concerning the possible prophylactic and/or therapeutic use of NRF2 activators in treating cognitive impairment-related conditions.
... A substantial literature also supports the cognitive enhancing effects of CA. In human tests, CA extract or dried herb improved cognitive function of healthy middle-aged and elderly (Wattanathorn et al., 2008;Dev et al., 2009) individuals as well as elderly subjects with mild cognitive impairment (Tiwari et al., 2008). These effects have been recapitulated in rodent models as well, where CA was shown to improve learning and memory in healthy rats (Veerendra Kumar and Gupta, 2002) and in mouse models of neurotoxicity Veerendra Kumar and Gupta, 2003). ...
... frontiersin.org studies (Veerendra Kumar and Wijeweera et al., 2006;Tiwari et al., 2008;Wattanathorn et al., 2008;Dev et al., 2009;Jana et al., 2010;Kalshetty et al., 2012;Selvi et al., 2012;Wanasuntronwong et al., 2012;Chanana and Kumar, 2016). Our group has previously shown that the water extract of C. asiatica (CAW) administered in the drinking water at 2 mg/mL (calculated to deliver 200 mg/kg/d CAW) improves cognitive function in mouse models of aging and neurodegenerative disease (Soumyanath et al., 2012;Gray et al., 2016;Gray et al., 2018a;Gray et al., 2018b;Matthews et al., 2019). ...
Article
Full-text available
Background: A water extract (CAW) of the Ayurvedic plant Centella asiatica administered in drinking water has been shown to improve cognitive deficits in mouse models of aging and neurodegenerative diseases. Here the effects of CAW administered in drinking water or the diet on cognition, measures of anxiety and depression-like behavior in healthy aged mice are compared. Methods: Three- and eighteen-month-old male and female C57BL6 mice were administered rodent AIN-93M diet containing CAW (0, 0.2, 0.5 or 1% w/w) to provide 0, 200 mg/kg/d, 500 mg/kg/d or 1,000 mg/kg/d CAW for a total of 5 weeks. An additional group of eighteen-month-old mice were treated with CAW (10 mg/mL) in their drinking water CAW for a total of 5 weeks to deliver the same exposure of CAW as the highest dietary dose (1,000 mg/kg/d). CAW doses delivered were calculated based on food and water consumption measured in previous experiments. In the fourth and fifth weeks, mice underwent behavioral testing of cognition, anxiety and depression (n = 12 of each sex per treatment group in each test). Results: Aged mice of both sexes showed cognitive deficits relative to young mice while only female aged mice showed increased anxiety compared to the young female mice and no differences in depression were observed between the different ages. CAW (1,000 mg/kg/d) in the drinking water improved deficits in aged mice in learning, executive function and recognition memory in both sexes and attenuated the increased measures of anxiety observed in the aged female mice. However, CAW in the diet only improved executive function in aged mice at the highest dose (1,000 mg/kg/d) in both sexes and did so less robustly than when given in the water. There were no effects of CAW on depression-like behavior in aged animals regardless of whether it was administered in the diet or the water. Conclusions: These results suggest that CAW can ameliorate age-related changes in measures of anxiety and cognition and that the mode of administration is important for the effects of CAW on resilience to these age-related changes.
... It may require an increase in dose and administration time of at least 6 months. This is in line with research on 41 healthy middle-aged people with a Gotu Kola dose of 1x3-4 gr/day for 2 months, slowing down age-related decline in cognitive function in healthy middle-aged and older adults (Dev et al., 2009). This is in accordance with research that Gotu Kola can protect against cognitive impairment and morphological changes in mice models of Alzheimer's dementia (Chiroma et al., 2019). ...
Article
Full-text available
Introduction: Broccoli and Gotu Kola (Brogandi) are known to improve cognitive function, but the combination of the two to improve cognitive function is still limited. Objective: This study aimed to analyze the effectiveness of Brogandi in improving cognitive function in healthy elderly, mild dementia and moderate dementia. Methods: This research used a pre and post test design on 38 elderly people at Griya Lansia Garut. Cognitive function examination uses the MMSE (Mini Mental State Examination) questionnaire. The dose of brogandi given is 2x500 mg/day for 14 weeks. Results: Brogandi can improve cognitive function in elderly with mild dementia (p=0.001). Conclusion: Giving Brogandi at a dose of 2x500mg/day for 14 weeks is effective in improving cognitive function in elderly with mild dementia. Meanwhile, in elderly people with moderate dementia, further research needs to be done in the form of increasing the dose and taking a longer administration time.
... Centella Asiatica (CA) Urban, (Apiaceae), familiar as Gotu Kola is used in traditional Chinese and Ayurvedic medicine to enhance memory, cure cognitive function, and inverse cognitive impairments (Shinomol et al., 2011). The neuroprotective and cognitive enhancing effects of CA extracts have been validated in human works (Dev et al., 2009;Tiwari et al., 2008) as well as in preclinical model systems (Veerendra-Kumar & Gupta, 2003;Defillipo et al., 2012). Previous studies have shown that CA can prevent Aβ toxicity in vitro (Gray et al., 2014), without changing plaque load (Soumyanath et al., 2012), and reduce cognitive impairments in a transgenic mouse model of Aβ accumulation. ...
Article
Aim: Parkinson's disease is qualified by advancing the loss of dopaminergic neurons and depletion of dopamine. However, the pathophysiological mechanisms need new perspectives for therapeutic strategies that alleviate and abolish neurodegenerative. The last searches have demonstrated that Centella Asiatica is commonly used in conventional medicine. The aim of our study is to reveal the neuroprotective effect of Centella Asiatica, which we will use in the treatment, on the neurotoxicity stimulated by 6 OHDA. Method: First, the SH-SY5Y cell line was grown in prepared media. Then, 25-50-75 and 100 µg/ml concentrations of Centella Asiatica were supplemented to the wells that reached 85% confluence 2 hours before (except for the control and 6-OHDA groups). Afterward, 200 µM 6-OHDA was added to the wells (except for the control group) and incubated for 24 hours. Then, IL-1β, GSH, MTT, LDH, GPx, TNF-α, SOD, MPO, CAT, and MDA analyses were performed. One-way analysis of variance was performed using the IBM SPSS 22.0 package program. The results were compared with the control and 6-OHDA groups, and values below p<.05 were considered statistically significant. Results: It was found that Centella Asiatica demonstrated a dose-dependent rise in the vivacity rate and the cell vivacity was 92% at the highest concentration. Moreover, antioxidant parameters (GSH, GPx, SOD, CAT) correlated with MTT and LDH assay. In IL-1β, TNF-α, MPO, and MDA activities, it was observed that the oxidant amount reduced depending on the concentration. Conclusion: These findings revealed that Centella Asiatica exerts a neuroprotective effect opposite 6-OHDA induction by rising cell viability and reducing oxidative stress.
... CA extract (CAE) has been thoroughly studied for its antioxidant and mitoprotective properties in various rodents' models of cognitive dysfunction (Chiroma et al., 2019b;Gray et al., 2017;Gupta and Flora, 2006;Veerendra Kumar and Gupta, 2003). The memory-enhancing effects of CA are also corroborated by a few small clinical trials on aged and older adults (Dev et al., 2009;Wattanathorn et al., 2008). However, only limited pieces of literature are available showing the cognition-enhancing and neuroprotective role of CA in aged rats (Gray et al., 2016(Gray et al., , 2018Subathra et al., 2005). ...
Article
Ethnopharmacological relevance: Centella asiatica (L.) Urban, is a medicinal herb with rich history of traditional use in Indian subcontinent. This herb has been valued for its diverse range of medicinal properties including memory booster, and also as a folk treatment for skin diseases, wound healing and mild diuretic. Aim of study: Aging is a gradual and continuous process of natural decay in the biological systems, including the brain. This work aims to evaluate the effectiveness of ethanolic extract of Centella asiatica (CAE) on ageassociated cognitive impairments in rats, as well as the underlying mechanism. Material and methods: Rats were allocated into five distinct groups of 5 animals each: Young rats (3 months old rats), middle-aged (m-aged) rats (13–14 months old), and the remaining three groups were comprised of maged rats treated with different concentrations of CAE, viz., 150, 300, and 450 mg/kg b. w., orally for 42 days. Y-maze, open field, novel object recognition, and elevated plus maze tests were used to assess animal behavior. The malondialdehyde (MDA), superoxide dismutase (SOD), and acetylcholinesterase (AChE) assays; and H&E staining were done in the rat brain to assess the biochemical and structural changes. CAE was also subjected to HPLC analysis, in vitro antioxidant and anti-cholinergic activity. The active compounds of CAE were docked with AChE and BuChE in molecular docking study. Results: The results showed that CAE treatment improves behavioral performance; attenuates the ageassociated increase in MDA content, SOD, and AChE activity; and reduces neuronal loss. In vitro study showed that CAE has concentration-dependent antioxidant and anti-AChE activity. Furthermore, the presence of Asiatic acid and Madecassic acid in CAE and their good binding with cholinergic enzymes (in silico) also suggest the anticholinergic effect of CAE. Conclusion: The findings of the current study show that the anticholinergic and antioxidant effects of CAE are attributable to the presence of Asiatic acid and Madecassic acid,
... In addition, DZXI treatment regulated the mitochondrial electron transport process, and the level of cytochrome C oxidase subunit 2 was significantly increased and protected the stability of neuronal mitochondria. Among the studies retrieved in the present study, there are two articles about Centella asiatica (CAW), which is a plant that used in traditional Chinese medicine to enhance memory and improve cognitive function (Kapoor, 1990;Wattanathorn et al., 2008;Dev et al., 2009;Shinomol et al., 2011;Sirichoat et al., 2015;Gray et al., 2016;Umka Welbat et al., 2016;Chaisawang et al., 2017). In patients with epilepsy, long-term use of the current antiepileptic drugs cannot improve cognitive function (Ortinski and Meador, 2004;77;Santulli et al., 2016). ...
Article
Full-text available
Medicines from natural products can not only treat neurodegenerative diseases but also improve the cognitive dysfunction caused by treatments with western medicines. This study reviews the literature related to the regulation of mitochondrial participation in cognitive function by natural products. In this study, we focused on English articles in PubMed, Web of Science, and Google Scholar, from 15 October 2017, to 15 October 2022. Fourteen studies that followed the inclusion criteria were integrated, analyzed, and summarized. Several studies have shown that natural products can improve or reduce cognitive dysfunction by ameliorating mitochondrial dysfunction. These results suggest that natural products may serve as new therapeutic targets for neurodegenerative diseases.
... C. asiatica is classified as a Class 1 herb by The Botanical Safety Handbook [86], meaning it can be consumed safely when correctly used. Its widespread use as a dietary supplement, the lack of reports found on the FDA CFSAN Adverse Event Reporting System (CAERS), and the available human studies support its safety [22,[87][88][89]. In this study, minor adverse events were reported, including headache and dry mouth, which resolved quickly (Table 5). ...
Article
Full-text available
Centella asiatica is reputed in Eastern medicine to improve cognitive function in humans. Preclinical studies have demonstrated that aqueous extracts of C. asiatica improve cognition in mouse models of aging and Alzheimer’s disease (AD) through the modulation of mitochondrial biogenesis and nuclear factor-erythroid-2-related factor 2 (Nrf2)-dependent antioxidant response genes. This randomized, double-blind, crossover Phase I trial explored the oral bioavailability and pharmacokinetics of key compounds from two doses (2 g and 4 g) of a standardized C. asiatica aqueous extract product (CAP), over 10 h, in four mildly demented older adults on cholinesterase inhibitor therapy. The analysis focused on triterpenes (TTs) and caffeoylquinic acids (CQAs), which are known to contribute to C. asiatica’s neurological activity. The acute safety of CAP and the effects on NRF2 gene expression in peripheral blood mononuclear cells were evaluated. Single administration of 2 g or 4 g of CAP was safe and well-tolerated. The TT aglycones, asiatic acid and madecassic acid, were identified in plasma and urine, while the parent glycosides, asiaticoside and madecassoside, although abundant in CAP, were absent in plasma and had limited renal excretion. Similarly, mono- and di-CQAs showed delayed absorption and limited presence in plasma or urine, while the putative metabolites of these compounds showed detectable plasma pharmacokinetic profiles and urinary excretion. CAP elicited a temporal change in NRF2 gene expression, mirroring the TT aglycone’s pharmacokinetic curve in a paradoxical dose-dependent manner. The oral bioavailability of active compounds or their metabolites, NRF2 target engagement, and the acute safety and tolerability of CAP support the validity of using CAP in future clinical studies.
Article
Full-text available
Botanical products are frequently sold as dietary supplements and their use by the public is increasing in popularity. However, scientific evaluation of their medicinal benefits presents unique challenges due to their chemical complexity, inherent variability, and the involvement of multiple active components and biological targets. Translation away from preclinical models, and developing an optimized, reproducible botanical product for use in clinical trials, presents particular challenges for phytotherapeutic agents compared to single chemical entities. Common deficiencies noted in clinical trials of botanical products include limited characterization of the product tested, inadequate placebo control, and lack of rationale for the type of product tested, dose used, outcome measures or even the study population. Our group has focused on the botanical Centella asiatica due to its reputation for enhancing cognition in Eastern traditional medicine systems. Our preclinical studies on a Centella asiatica water extract (CAW) and its bioactive components strongly support its potential as a phytotherapeutic agent for cognitive decline in aging and Alzheimer's disease through influences on antioxidant response, mitochondrial activity, and synaptic density. Here we describe our robust, scientific approach toward developing a rational phytotherapeutic product based on Centella asiatica for human investigation, addressing multiple factors to optimize its valid clinical evaluation. Specific aspects covered include approaches to identifying an optimal dose range for clinical assessment, design and composition of a dosage form and matching placebo, sourcing appropriate botanical raw material for product manufacture (including the evaluation of active compounds and contaminants), and up-scaling of laboratory extraction methods to available current Good Manufacturing Practice (cGMP) certified industrial facilities. We also address the process of obtaining regulatory approvals to proceed with clinical trials. Our study highlights the complexity of translational research on botanicals and the importance of identifying active compounds and developing sound analytical and bioanalytical methods for their determination in botanical materials and biological samples. Recent Phase I pharmacokinetic studies of our Centella asiatica product in humans (NCT03929250, NCT03937908) have highlighted additional challenges associated with designing botanical bioavailability studies, including specific dietary considerations that need to be considered.
Article
Full-text available
Centella asiatica is rich in pentacyclic triterpenes that have been associated with several beneficial health effects. Several earlier studies investigated the effects of long term intake of C. asiatica on several cognitive functions and mood, either in the form of dried herb, powder, supplements or extract, but not as a fresh herb in a human intervention study. In this research, for the first time, the short-term effect of consuming a single smoothie, containing two concentrations of the fresh herb, on the cognition and mood of healthy female participants was investigated. Madecassic acid was the major triterpene in the fresh leaves of C. asiatica. Cognitive performance and mood dimensions were assessed before and one hour after consuming a single serving of smoothies. Alertness and contentedness factors significantly improved with higher concentration of C. asiatica. No significant improvements in cognitive functions after one hour of consumption were found.
Article
Full-text available
If rodents do not display the behavioral complexity that is subserved in primates by prefrontal cortex, then evolution of prefrontal cortex in the rat should be doubted. Primate prefrontal cortex has been shown to mediate shifts in attention between perceptual dimensions of complex stimuli. This study examined the possibility that medial frontal cortex of the rat is involved in the shifting of perceptual attentional set. We trained rats to perform an attentional set-shifting task that is formally the same as a task used in monkeys and humans. Rats were trained to dig in bowls for a food reward. The bowls were presented in pairs, only one of which was baited. The rat had to select the bowl in which to dig by its odor, the medium that filled the bowl, or the texture that covered its surface. In a single session, rats performed a series of discriminations, including reversals, an intradimensional shift, and an extradimensional shift. Bilateral lesions by injection of ibotenic acid in medial frontal cortex resulted in impairment in neither initial acquisition nor reversal learning. We report here the same selective impairment in shifting of attentional set in the rat as seen in primates with lesions of prefrontal cortex. We conclude that medial frontal cortex of the rat has functional similarity to primate lateral prefrontal cortex.
Article
Full-text available
The past five years have seen an outpouring of neuroimaging studies of memory — using both positron emission tomography (PET) and functional magnetic resonance imaging (fMRI). These studies have convincingly demonstrated that neuroimaging can be used to study the functional anatomy of normal human memory and that neuroimaging can precisely localize memory related brain activations within small areas of cortex. As one illustration of the application of neuroimaging in the study of memory, this review shows how several laboratories have produced data that converge on the notion that specific areas in the prefrontal cortex are active during long-term memory retrieval. Moreover, the data further suggest that distinct prefrontal brain areas might make differential contributions to different kinds of long-term memory retrieval.
Article
We review evidence for partially segregated networks of brain areas that carry out different attentional functions. One system, which includes parts of the intraparietal cortex and superior frontal cortex, is involved in preparing and applying goal-directed (top-down) selection for stimuli and responses. This system is also modulated by the detection of stimuli. The other system, which includes the temporoparietal cortex and inferior frontal cortex, and is largely lateralized to the right hemisphere, is not involved in top-down selection. Instead, this system is specialized for the detection of behaviourally relevant stimuli, particularly when they are salient or unexpected. This ventral frontoparietal network works as a 'circuit breaker' for the dorsal system, directing attention to salient events. Both attentional systems interact during normal vision, and both are disrupted in unilateral spatial neglect.
Article
The cognitive functions of the prefrontal cortex (PFC), which include use of working memory to guide behavioral responses and the contents of attentional focus, the inhibition of inappropriate responses, and planning for the future, are among the most fragile in our behavioral repetoire. Deficits in PFC function are evident in every neuropsychiatric disorder. Many of these changes clearly result from transient, neurochemcial changes in the PFC, and research in animals indicates that the PFC is tremendously sensitive to its neurochemical environment. This chapter will review research from both animal and human studies on the ways in which dopamine (DA), norepinephrine (NE), serotonin (5HT), and acetylcholine (ACh) may modulate PFC cognitive functions. (PsycINFO Database Record (c) 2012 APA, all rights reserved)
Article
Positron emission tomography (PET) with the tracer Ha215O was used to measure regional cerebral blood flow in 13 healthy volunteers while they engaged in free recall of 15-item word lists from the Rey Auditory Verbal Learning task. The study was designed so that recall of well-practiced versus novel material could be compared. One week before the PET study, subjects were trained to perfect recall of List A, while they were exposed to list B only 60s prior to PET data acquisition. As in the companion study of free recall of complex narratives, we observed that practice tended to decrease the size of activations in regions involved in the memory component of the task; we also observed that the novel recall task produced greater activation in left frontal regions, probably due to active encoding. A commonality of other regions observed in this pair of studies, as well as other studies of memory in the literature, suggests that the human brain may contain a distributed multinodal general memory system. Nodes on this network include the frontal, parietal, and temporal cortices, the thalamus, the anterior and posterior cingulate, the precuneus, and the cerebellum. There appears to be a commonality of components across tasks (e.g., retrieval, encoding) that is independent of content, as well as differentiation of some components that may be content-specific or task-specific. In addition, these results support a significant role for the cerebellum in cognitive functions such as memory.
Article
The frontal lobe is not a single anatomical and functional brain region. Several lines of research have demonstrated that particular subregions within the frontal lobe are associated with specific motor and cognitive functions in the human being. Our main purpose is to develop a magnetic resonance image (MRI)-based parcellation method of the frontal lobe that permits us to explore plausible abnormalities in functionally relevant frontal subregions in brain illnesses. We describe a procedure using MRI for subdividing the entire frontal cortex into 11 subregions: supplementary motor area (SMA), rostral anterior cingulate gyrus (r-ACiG), caudal anterior cingulate gyrus (c-ACiG), superior cingulate gyrus (SCiG), medial frontal cortex (MFC), straight gyrus (SG), orbitofrontal cortex (OFC), precentral gyrus (PCG), superior frontal gyrus (SFG), inferior frontal gyrus (IFG), and middle frontal gyrus (MFG). Our method posits to conserve the topographic uniqueness of individual brains and is based on our ability to visualize both the three-dimensional (3D) rendered brain and the three orthogonal planes simultaneously. The reliability study for gray matter volume and surface area of each subregion was performed on a set of 10 MR scans by two raters. The intraclass R coefficients for gray matter volume of each subregion ranged between 0.86 and 0.99. We describe here a reproducible and reliable topography-based parcellation method of the frontal lobe that will allow us to use new approaches to understand the role of particular frontal cortical subregions in schizophrenia and other brain illnesses.